AKTS - Triple top patternAKTS - Triple top pattern, in 3 mins 15 mins and 1 hour candle sticks , AKTS - Triple top pattern
Short
Aktis Oncology, Inc.
No trades
No trades
Compare with Aktis Oncology, Inc.
−63.73 M USD
6.50 M USD
31.79 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Profile
Sector
Industry
CEO
Matthew Roden
Website
Headquarters
Boston
Founded
2020
IPO date
Jan 9, 2026
IPO offer price
18.00 USD
ISIN
US01021M1045
CUSIP
01021M104
FIGI
BBG00ZQS8KZ1
Identifiers
ISIN US01021M1045
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
Short
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Weight1.72%
Market value1.54 M
Weight0.74%
Market value400.68 K
Weight0.01%
Market value209.22 K
Weight0.03%
Market value91.42 K
Weight0.17%
Market value39.87 K
Weight0.03%
Market value1.03 K
Explore more ETFs
Frequently asked questions
The current price of AKTS is 25.58 USD — it has decreased by −10.33% in the past 24 hours. Watch Aktis Oncology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aktis Oncology, Inc. stocks are traded under the ticker AKTS.
AKTS stock has fallen by −21.26% compared to the previous week, the month change is a 17.04% rise, over the last year Aktis Oncology, Inc. has showed a 13.92% increase.
We've gathered analysts' opinions on Aktis Oncology, Inc. future price: according to them, AKTS price has a max estimate of 40.00 USD and a min estimate of 33.00 USD. Watch AKTS chart and read a more detailed Aktis Oncology, Inc. stock forecast: see what analysts think of Aktis Oncology, Inc. and suggest that you do with its stocks.
AKTS reached its all-time high on Jun 30, 2026 with the price of 34.19 USD, and its all-time low was 14.72 USD and was reached on Mar 30, 2026. View more price dynamics on AKTS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AKTS stock is 14.94% volatile and has beta coefficient of 2.04. Track Aktis Oncology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Aktis Oncology, Inc. there?
Today Aktis Oncology, Inc. has the market capitalization of 1.54 B, it has increased by 7.88% over the last week.
Yes, you can track Aktis Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
Aktis Oncology, Inc. is going to release the next earnings report on Sep 2, 2026. Keep track of upcoming events with our Earnings Calendar.
AKTS earnings for the last quarter are −0.38 USD per share, whereas the estimation was −0.36 USD resulting in a −5.11% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about Aktis Oncology, Inc. earnings.
Aktis Oncology, Inc. revenue for the last quarter amounts to 3.23 M USD, despite the estimated figure of 1.93 M USD. In the next quarter, revenue is expected to reach 2.08 M USD.
AKTS net income for the last quarter is −18.32 M USD, while the quarter before that showed −15.14 M USD of net income which accounts for 0.00% change. Track more Aktis Oncology, Inc. financial stats to get the full picture.
No, AKTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 14, 2026, the company has 79 employees. See our rating of the largest employees — is Aktis Oncology, Inc. on this list?
Like other stocks, AKTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aktis Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.